Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model.
Takeda M, Sakamoto H, Shibasaki N, Fukui T, Magaribuchi T, Sumiyoshi T, Utsunomiya N, Sawada A, Goto T, Kobayashi T, Ueda K, Yamasaki T, Ogawa O, Akamatsu S. Takeda M, et al. Among authors: shibasaki n. Front Oncol. 2023 Mar 23;13:1139049. doi: 10.3389/fonc.2023.1139049. eCollection 2023. Front Oncol. 2023. PMID: 37064121 Free PMC article.
Genome-Wide Association Study and Transcriptome of Japanese Patients with Developmental Dysplasia of the Hip Demonstrates an Association with the Ferroptosis Signaling Pathway.
Mori Y, Ueno K, Chiba D, Hashimoto K, Kawai Y, Baba K, Tanaka H, Aki T, Ogasawara M, Shibasaki N, Tokunaga K, Aizawa T, Nagasaki M. Mori Y, et al. Among authors: shibasaki n. Int J Mol Sci. 2023 Mar 6;24(5):5019. doi: 10.3390/ijms24055019. Int J Mol Sci. 2023. PMID: 36902448 Free PMC article.
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction.
Kita Y, Ito K, Kanda S, Joraku A, Yamaguchi R, Shimizu Y, Hayata N, Somiya S, Shibasaki N, Kimura T, Hikami K, Yamada T, Abe T, Tsuchihashi K, Tatarano S, Nishiyama H, Kitamura H, Kobayashi T. Kita Y, et al. Among authors: shibasaki n. Urol Oncol. 2022 Sep;40(9):410.e11-410.e18. doi: 10.1016/j.urolonc.2022.04.005. Epub 2022 May 9. Urol Oncol. 2022. PMID: 35551861
Preoperative ipilimumab/nivolumab combination therapy reduced operation risk by downstaging the inferior vena cava tumor thrombus extending to the right atrium in a metastatic renal cell carcinoma: A case report.
Otsuka H, Masui K, Hosomi T, Makino Y, Shibasaki N, Shichiri Y. Otsuka H, et al. Among authors: shibasaki n. Urol Case Rep. 2021 Oct 23;40:101912. doi: 10.1016/j.eucr.2021.101912. eCollection 2022 Jan. Urol Case Rep. 2021. PMID: 34777999 Free PMC article.
Functional and genomic characterization of patient-derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma.
Sakamoto H, Yamasaki T, Sumiyoshi T, Takeda M, Shibasaki N, Utsunomiya N, Arakaki R, Akamatsu S, Kobayashi T, Inoue T, Kamba T, Nakamura E, Ogawa O. Sakamoto H, et al. Among authors: shibasaki n. Cancer Med. 2021 Jan;10(1):119-134. doi: 10.1002/cam4.3578. Epub 2020 Oct 27. Cancer Med. 2021. PMID: 33107222 Free PMC article.
[A Case of Small Cell Carcinoma of the Bladder].
Ota H, Yamaguchi T, Tsuruta M, Fuchigami Y, Magaribuchi T, Naito H, Iguchi R, Shibasaki N, Terai A. Ota H, et al. Among authors: shibasaki n. Hinyokika Kiyo. 2020 Sep;66(9):313-317. doi: 10.14989/ActaUrolJap_66_9_313. Hinyokika Kiyo. 2020. PMID: 32988169 Free article. Japanese.
38 results